Why is Bliss GVS Pharma falling/rising?

As of 07-Jul, Bliss GVS Pharma Ltd's stock price is currently at Rs 163.00, reflecting an increase of Rs 6.65 or 4.25%. The stock has shown strong performance today, outperforming its sector by 4.33% and reaching an intraday high of Rs 164.75. Over the past week, the stock has increased by 2.77%, and it has delivered a remarkable 19.11% return over the last month, significantly outpacing the Sensex, which has only risen by 1.53%. However, despite these positive short-term movements, the company has experienced a decline in profits, with a -19.5% drop over the past year, and it has reported negative results for the last three consecutive quarters. This mixed performance, alongside a low Debt to Equity ratio and a fair valuation, suggests that while the stock is currently rising, there are underlying concerns regarding long-term growth.
Broader market context indicates that Bliss GVS Pharma's recent performance is notably strong compared to the benchmark. The stock has outperformed the Sensex over various periods, including a 42.98% return over the past year compared to the Sensex's 4.31%. However, it is essential to note that the stock's long-term growth prospects appear limited, as indicated by a -2.54% annual growth rate in operating profit over the last five years. Additionally, the lack of domestic mutual fund investment may reflect a broader market skepticism regarding the company's future performance. Overall, while the stock is currently rising, the mixed signals from its financial health and market perception suggest caution moving forward.